Researchers reported durable immune responses to cancer cells up to four years after receiving a personalized vaccine

New research published in the journal Nature is outlining the long-term efficacy of a novel type of cancer vaccine. The research followed eight skin cancer patients and discovered the experimental treatment offers durable and persistent immune responses to cancer cells up to four years later.

Continue Reading

Category: Medical, Science

Tags: , , , , ,



Weiterlesen...